Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Other Non-Current Liabilities (2018 - 2023)

Historic Other Non-Current Liabilities for cbdMD (YCBD) over the last 6 years, with Q4 2023 value amounting to $20611.0.

  • cbdMD's Other Non-Current Liabilities fell 9041.35% to $20611.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $20611.0, marking a year-over-year decrease of 9041.35%. This contributed to the annual value of $90363.0 for FY2023, which is 6725.98% down from last year.
  • Per cbdMD's latest filing, its Other Non-Current Liabilities stood at $20611.0 for Q4 2023, which was down 9041.35% from $90363.0 recorded in Q3 2023.
  • cbdMD's 5-year Other Non-Current Liabilities high stood at $102.3 million for Q1 2019, and its period low was $20611.0 during Q4 2023.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $8.8 million (2020), whereas its average is $18.6 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 88195897.05% in 2019, then tumbled by 9934.82% in 2021.
  • Quarter analysis of 5 years shows cbdMD's Other Non-Current Liabilities stood at $33.7 million in 2019, then fell by 26.71% to $24.7 million in 2020, then crashed by 99.35% to $161000.0 in 2021, then surged by 33.54% to $215000.0 in 2022, then crashed by 90.41% to $20611.0 in 2023.
  • Its Other Non-Current Liabilities stands at $20611.0 for Q4 2023, versus $90363.0 for Q3 2023 and $122230.0 for Q2 2023.